MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$5,446,255
Change in fair value of
warrants
-$25,831
Loss from operations
-$5,400,920
Interest expense, net
-$71,166
Total operating
expenses
$5,400,920
Research and development
$3,134,810
General and
administrative
$2,266,110
Back
Back
Income Statement
source: myfinsight.com
Tevogen Bio Holdings Inc. (TVGN)
Tevogen Bio Holdings Inc. (TVGN)